CPC A61K 9/5031 (2013.01) [A01N 25/10 (2013.01); A01N 25/28 (2013.01); A01N 37/10 (2013.01); A01N 37/18 (2013.01); A01N 43/70 (2013.01); A01N 47/30 (2013.01); A61K 9/4866 (2013.01); A61K 9/5089 (2013.01); A61K 31/11 (2013.01); A61K 31/192 (2013.01); A61K 31/555 (2013.01); B01J 13/16 (2013.01)] | 10 Claims |
1. A partially bio-based polyurethane microcapsule for sustained release of an active ingredient comprising;
i) a core containing at least one active ingredient selected from the group consisting of dimethyl phthalate, N,N-Diethyl-meta-toluamide (DEET), Ibuprofen, Diuron, Zinc Pyrithione, Irgarol, and 4-Anisaldehyde; and
ii) a bio-compatible polymeric shell consisting of (a) a bio-based aliphatic diol, (b) an aliphatic diisocyanate, (c) a cross linker and (d) an additive; wherein the bio-based aliphatic diol is selected from the group consisting of isosorbide, 1,3-propane diol, 1,4-butane diol, 2,3-butane diol, and 1,6-hexane diol and the aliphatic diisocyanate is selected from the group consisting of 1,6 Hexamethylene diisocyanates (HMDI), Isophorone diisocyanate (IPDI), pentamethylene diisocyanates (PDI), and 4,4′-Diisocyanatodicyclohexylmethane (H12 MDI); wherein said additive is selected from the group consisting of nanocellulose, nanoclay, nanosilica and carbon nanotube (CNT);
wherein, the mole ratio of diisocyanate to hydroxyl groups present in aliphatic diol is 1.2:1;
and wherein, the partially bio-based polyurethane microcapsule has an encapsulation efficiency of 70-95%.
|